Contrave (naltrexone/bupropion) for weight loss: honest guide
Contrave is a US FDA-approved weight-loss pill that pairs two older medicines, naltrexone and bupropion, into one extended-release tablet. It works on brain pathways that control hunger and food reward, and the honest weight-loss result in trials was modest, around 5 to 8 percent of body weight. It is not approved or marketed in India as a standard combination, and it carries real risks, including seizures from bupropion and rising blood pressure. This guide gives the plain picture and tells you to ask your doctor.
You may have heard of a weight-loss pill called Contrave that 'switches off cravings'. The honest story is a little different. Contrave is a real, regulated medicine, approved by the US Food and Drug Administration (FDA) for weight management, but it is two older drugs joined together, the weight loss in studies was modest, and the pill has genuine risks. In India this exact combination is not a standard, locally approved option. This guide gives you the plain facts, the real numbers from trials, the side effects and the serious warnings, and tells you clearly to talk to your doctor before any decision.
The baseline: what Contrave is and how it is thought to work
Contrave is an extended-release tablet that contains two drugs: naltrexone and bupropion. The US FDA label says it is 'indicated in combination with a reduced-calorie diet and increased physical activity to reduce excess body weight and maintain weight reduction long term in adults with obesity or overweight in the presence of at least one weight-related comorbid condition'. So it is meant to be used with diet and movement, not as a replacement for them. The two drugs are thought to team up on the brain. Bupropion works on dopamine and norepinephrine, the brain chemicals linked to drive and reward. Naltrexone blocks opioid receptors, which are part of the food-reward loop. The label explains it simply: the combination has 'naltrexone, an opioid antagonist, and bupropion, a relatively weak inhibitor of the neuronal reuptake of dopamine and norepinephrine'. A peer-reviewed review adds that the two are thought to 'work synergistically in the hypothalamus and the mesolimbic dopamine circuit to promote satiety, reduce food intake, and enhance energy expenditure'. Importantly, the same review notes that 'the exact neurochemical mechanism of the naltrexone/bupropion combination leading to weight loss is not fully understood'. So this is a medicine that tweaks brain reward and fullness signals, not a pill that burns fat. Your doctor decides if it fits you, and the dose is built up slowly, not started at the full amount.
Contrave blocks food cravings, so it works like willpower in a pill and melts the fat away.
mostly falseMostly false and oversold. Contrave does act on brain reward and fullness pathways, but the makers' own published review says 'the exact neurochemical mechanism of the naltrexone/bupropion combination leading to weight loss is not fully understood'. It does not melt fat; the weight loss in the four main trials was modest, about 5 to 8 percent of body weight, and the extra loss beyond a placebo was only about 3 to 5 percent. In the COR-BMOD trial, the best result, people on the drug lost about 8.1 percent versus 4.9 percent on placebo, so a big chunk of the loss came from the diet and behaviour change, not the drug alone. The FDA label also says to stop if you have not lost at least 5 percent of body weight by 12 weeks, because many people do not respond. So it is not willpower in a pill. It is a modest helper that, for some people, makes diet and activity changes a little more effective, and only a doctor can tell if it is right for you.
Safe use, the real risks, and the honest India status
- Talk to your doctor first. Contrave is prescription-only and the dose is built up over weeks. Your doctor decides if it fits your health and sets the dose, you do not.
- Know the serious warnings. The FDA label says 'Bupropion, a component of CONTRAVE, can cause seizures. The risk of seizure is dose-related.' It also says 'CONTRAVE can cause an increase in systolic and/or diastolic blood pressure as well as an increase in resting heart rate.' So your blood pressure and heart rate need checking.
- Respect the contraindications. The label lists them plainly: 'Uncontrolled hypertension', 'Seizure disorder or a history of seizures', 'Bulimia or anorexia nervosa, which increase the risk for seizure', 'Chronic opioid or opiate agonist (e.g., methadone) or partial agonists (e.g., buprenorphine) use, or acute opiate withdrawal', and 'Concomitant administration of monoamine oxidase inhibitors (MAOI)'. If any of these fit you, Contrave is off the table.
- Watch the mood warning. The label carries a boxed warning that 'Antidepressants increased the risk of suicidal thoughts and behavior in children, adolescents, and young adults in short-term trials' and notes 'serious neuropsychiatric adverse events have been reported in patients taking bupropion for smoking cessation'. Tell your doctor about any past depression or suicidal thoughts.
- Expect common side effects. The label lists 'nausea, constipation, headache, vomiting, dizziness, insomnia, dry mouth and diarrhea'. Nausea is the most common and the main reason people stop the drug in trials.
- Be honest about India. Contrave is a US FDA-approved combination, but it is not a standard, locally approved prescription option in India. It is not a CDSCO-listed fixed-dose combination for obesity. What is available in India are the two drugs used separately for other problems: naltrexone for opioid and alcohol dependence, and bupropion for depression and smoking cessation. Some import suppliers list Contrave sourced from Canada, but that is a special-order import, not a normal Indian pharmacy product.
- Ask your doctor about the India reality. Do not order weight-loss pills online. Whether Contrave is even legally and safely obtainable for you in India, and whether a different, locally available option suits you better, is a question for your doctor, not an online ad.
The bottom line
Contrave is a real, US FDA-approved weight-loss medicine that pairs naltrexone and bupropion to nudge brain reward and fullness signals. The honest result from trials is modest, about 5 to 8 percent weight loss, with only about 3 to 5 percent beyond a placebo, and the FDA says to stop if you have not lost at least 5 percent by 12 weeks. It carries real risks, including seizures from bupropion, rising blood pressure and heart rate, neuropsychiatric and suicidality warnings, and a list of contraindications such as uncontrolled hypertension, seizure disorder, bulimia or anorexia, opioid use, and MAOI drugs. In India this exact combination is not a standard, locally approved option; only the two separate drugs are available for other uses, and import listings are special-order, not normal pharmacy stock. So the simple, honest path is the same one: talk to your doctor, do not self-order online, and build the weight-loss base with food and activity. Burnie can help you log your food and see your daily calorie deficit, but medicine decisions belong with your doctor.